- Phase
- Approved (PMA)
- Design type
- NCT06787690: Multicentre, single-arm trial. NCT06750809: Randomised controlled trial, multicentre.
- Primary endpoint
- [ TODO: fill in ] (primary endpoint details not specified in available trial registry data for NCT06787690 or NCT06750809)
- Key secondary endpoints
- Clinical outcomes in full-thickness wounds (NCT06787690, per ClinicalTrials.gov)
- Associated costs of wound management (NCT06750809, per ClinicalTrials.gov)
- [ TODO: fill in ] additional secondary endpoints
- Enrolment target
- 41 patients (NCT06787690, per ClinicalTrials.gov); 40 patients (NCT06750809, per ClinicalTrials.gov)
- Current enrolment status
- Both NCT06787690 and NCT06750809 are listed as Active, Not Recruiting (per ClinicalTrials.gov)
- Sites
- [ TODO: fill in ]
- Expected readout window
- Primary completion dates are 2026-02-10 for NCT06787690 and 2026-05-01 for NCT06750809 (per ClinicalTrials.gov); both trials are active and not recruiting, suggesting data collection is ongoing or recently concluded.